Acute Eosinophilic Myocarditis International Registry
- Conditions
- Myocarditis
- Interventions
- Other: No intervention
- Registration Number
- NCT06447935
- Lead Sponsor
- Niguarda Hospital
- Brief Summary
Retrospective collection of clinical, histological, imaging data regarding patients with acute histologically-proven eosinophilic myocarditis.
- Detailed Description
Eosinophilic myocarditis (EM) is an acute life-threatening inflammatory disease of the heart. We collect clinical, histologic, laboratory, diagnostic and imaging data regarding acute EM with a histological diagnosis and symptoms onset within 30 days from first medical contact from hospitals around the world. The main objective is to investigate and describe clinical presentation, main systemic conditions associated and outcomes of the first series of patients with acute myocarditis and histological evidence of eosinophilic infiltration within myocardium.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Acute Eosinophilic Myocarditis No intervention Patients affected by Acute Eosinophilic Myocarditis with the following inclusion criteria: 1. histologically EM proven "borderline" (presence of inflammatory infiltrate) or "active" (presence of inflammatory infiltrate plus myocardial necrosis) myocarditis, according to the Dallas criteria; 2. acute presentation defined by the onset of cardiac symptoms within 30 days before admission.
- Primary Outcome Measures
Name Time Method Natural History of Eosinophilic Myocarditis 3 year Proportion of patients who die or need a heart transplantation from index admission.
- Secondary Outcome Measures
Name Time Method Natural History of Eosinophilic Myocarditis subgroups based on etiology 3 years Proportion of patients who die or need a heart transplantation from index admission dividing patients based on the underlying condition (for instance idiopathic, hypersensitivity, eosinophilic granulomatosis with polyangiitis,...)
Trial Locations
- Locations (1)
ASST GOM Niguarda
🇮🇹Milano, Italy